Cargando…

Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer

TKI therapy has shown excellent efficacy and favorable tolerability in patients with mutation-positive nonsmall cell lung cancer. However, there is no clear consensus on the role of TKI as induction therapy. In this article, we reviewed recently published studies to analyze the benefits of tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Juejun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752212/
https://www.ncbi.nlm.nih.gov/pubmed/33165003
http://dx.doi.org/10.1097/CCO.0000000000000696